J&J to acquire Proteologix for US0 million

J&J to acquire Proteologix for US$850 million

May 16, 2024 / NYJ Editorial Desk /

[ad_1]

JOHNSON & Johnson said on Thursday (May 16) it would acquire Proteologix for US$850 million in cash, as it looks to gain access to the privately held company’s experimental atopic dermatitis treatments.

[ad_2]

Source link

Posted in

NYJ Editorial Desk

I am an editor for Ny Journals, focusing on business and entrepreneurship. I love uncovering emerging trends and crafting stories that inspire and inform readers about innovative ventures and industry insights.

Leave a Comment